期刊文献+

Design of Dendrimer Modified Carbon Nanotubes for Gene Delivery

Design of Dendrimer Modified Carbon Nanotubes for Gene Delivery
下载PDF
导出
摘要 To investigate the efficiency of polyamidoamine dendrimer grafted carbon nanotube (dendrimer-CNT) mediated entrance of anti-survivin oligonucleotide into MCF-7 cells, and its effects on the growth of MCF-7 cells. Methods: Antisense survivin oligonucleotide was anchored onto polyamidoamine dendrimer grafted carbon nanotubes to form dendrimer-CNT-asODN complex and the complex was characterized by Zeta potential, AFM, TEM, and 1% agarose gel electrophoresis analysis. Dendrimer-CNT-asODN complexes were added into the medium and incubated with MCF-7 cells. MTT method was used to detect the effects of asODN and dendrimer-CNT-asODN on the growth of MCF-7 cells. TEM was used to observe the distribution of dendrimer-CNT-asODN complex within MCF-7 cells. Results: Successful synthesis of dendrimer-CNT-asODN complexes was proved by TEM, AFM and agarose gel electrophoresis. TEM showed that the complexes were located in the cytoplasm, endosome, and lysosome within MCF-7 cells. When dendrimer-CNT-asODN (1.0 μmol/L) and asODN (1.0 μmol/L) were used for 120 h incubation, the inhibitory rates of MCF-7 cells were (28.22±3.5)% for dendrimer-CNT-asODN complex group, (9.23±0.56)% for only asODN group, and (3.44±0.25)% for dendrimer-CNT group. Dendrimer-CNT-asODN complex at 3.0 μmol/L inhibited MCF-7 cells by (30.30±10.62)%, and the inhibitory effects were in a time- and concentration-dependent manner. Conclusion: Dendrimer-CNT nanoparticles may serve as a gene delivery vector with high efficiency, which can bring foreign gene into cancer cells, inhibiting cancer cell proliferation and markedly enhancing the cancer therapy effects. To investigate the efficiency of polyamidoamine dendrimer grafted carbon nanotube (dendrimer-CNT) mediated entrance of anti-survivin oligonucleotide into MCF-7 cells, and its effects on the growth of MCF-7 cells. Methods: Antisense survivin oligonucleotide was anchored onto polyamidoamine dendrimer grafted carbon nanotubes to form dendrimer-CNT-asODN complex and the complex was characterized by Zeta potential, AFM, TEM, and 1% agarose gel electrophoresis analysis. Dendrimer-CNT-asODN complexes were added into the medium and incubated with MCF-7 cells. MTT method was used to detect the effects of asODN and dendrimer-CNT-asODN on the growth of MCF-7 cells. TEM was used to observe the distribution of dendrimer-CNT-asODN complex within MCF-7 cells. Results: Successful synthesis of dendrimer-CNT-asODN complexes was proved by TEM, AFM and agarose gel electrophoresis. TEM showed that the complexes were located in the cytoplasm, endosome, and lysosome within MCF-7 cells. When dendrimer-CNT-asODN (1.0 μmol/L) and asODN (1.0 μmol/L) were used for 120 h incubation, the inhibitory rates of MCF-7 cells were (28.22±3.5)% for dendrimer-CNT-asODN complex group, (9.23±0.56)% for only asODN group, and (3.44±0.25)% for dendrimer-CNT group. Dendrimer-CNT-asODN complex at 3.0 μmol/L inhibited MCF-7 cells by (30.30±10.62)%, and the inhibitory effects were in a time- and concentration-dependent manner. Conclusion: Dendrimer-CNT nanoparticles may serve as a gene delivery vector with high efficiency, which can bring foreign gene into cancer cells, inhibiting cancer cell proliferation and markedly enhancing the cancer therapy effects.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2007年第1期1-6,共6页 中国癌症研究(英文版)
基金 This project was supported by the National Natural Science Foundation of China (No. 30471599) the National 973 project (2005CB724300-G) the Bio-X DNA Computer Consortium (03DZ14025).
关键词 Gene delivery Carbon nanotube Polyamidoamine dendrimer Cancer therapy Survivin gene Gene delivery Carbon nanotube Polyamidoamine dendrimer Cancer therapy Survivin gene
  • 相关文献

参考文献20

  • 1Morris KV, Chan SW, Jacobsen SE, et al. Small interfering RNA-induced transcriptional gene silencing in human cells [J]. Science 2004;305:1289-92.
  • 2Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature [J]. Science 2002; 296:2404-7.
  • 3Salem AK, Searson PC, Leong KW. Multifunctional nanorods for gene delivery [J]. Nat Mater 2003; 2: 668-71.
  • 4Pack DW, Hoffman AS, Pun S, et al. Design and development of polymers for gene delivery [J]. Nat Rev Drug Discov 2005; 4:581-93.
  • 5Cai D, Mataraza JM, Qin ZH, et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing [J]. Nat Methods 2005; 2: 449-54.
  • 6Uchida H, Tanaka T, Sasaki K, et al. Adenovirusmediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo [J]. Mol Ther 2004; 10:162-71.
  • 7Fuessel S, Herrmann J, Ning S, el al. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA [J]. Cancer Lett 2006; 232:243-54.
  • 8Yamamoto T, Manome Y, Nakamura M, et al. Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer [J]. Eur J Cancer 2002; 38:2316-24.
  • 9Kong HJ, Liu J, Riddle K, et al. Non-viral gene delivery regulated by stiffenss of cell adhesion substrates [J]. Nat Mater 2005; 4:460-4.
  • 10Sengupta S, Eavarone D, Capila I, et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system [J]. Nature 2005; 436: 568-72.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部